103 related articles for article (PubMed ID: 22554769)
1. Discovery of a novel orally active PDE-4 inhibitor effective in an ovalbumin-induced asthma murine model.
Kwak HJ; Nam JY; Song JS; No Z; Yang SD; Cheon HG
Eur J Pharmacol; 2012 Jun; 685(1-3):141-8. PubMed ID: 22554769
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets.
Asaka N; Kakuo H; Ohmori K; Sasaki E; Togawa M; Yamada S; Oka T; Kiniwa M
Arzneimittelforschung; 2010; 60(9):564-70. PubMed ID: 21117500
[TBL] [Abstract][Full Text] [Related]
3. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
4. Anti-asthmatic effect of ASP3258, a novel phosphodiesterase 4 inhibitor.
Kobayashi M; Kubo S; Hirano Y; Kobayashi S; Takahashi K; Shimizu Y
Int Immunopharmacol; 2012 Jan; 12(1):50-8. PubMed ID: 22036845
[TBL] [Abstract][Full Text] [Related]
5. Cessation of dexamethasone exacerbates airway responses to methacholine in asthmatic mice.
Stengel PW; Nickell LE; Wolos JA; Snyder DW
Eur J Pharmacol; 2007 Jun; 563(1-3):213-5. PubMed ID: 17374534
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of GSK256066, a high-affinity inhaled phosphodiesterase 4 inhibitor.
Nials AT; Tralau-Stewart CJ; Gascoigne MH; Ball DI; Ranshaw LE; Knowles RG
J Pharmacol Exp Ther; 2011 Apr; 337(1):137-44. PubMed ID: 21205924
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
[TBL] [Abstract][Full Text] [Related]
9. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
[TBL] [Abstract][Full Text] [Related]
11. Effects of furosemide on allergic asthmatic responses in mice.
Wang S; Xiang YY; Ellis R; Wattie J; Feng M; Inman MD; Lu WY
Clin Exp Allergy; 2011 Oct; 41(10):1456-67. PubMed ID: 21729180
[TBL] [Abstract][Full Text] [Related]
12. [Effect of phosphodiestrase 4 inhibitor (rolipram) on experimental allergic asthma-guinea pig model].
Nejman-Gryz P; Grubek-Jaworska H; Glapińiski J; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):106-12. PubMed ID: 17175988
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Cissampelos sympodialis and its isolated alkaloid warifteine in airway hyperreactivity and lung remodeling in a mouse model of asthma.
Bezerra-Santos CR; Vieira-de-Abreu A; Vieira GC; Filho JR; Barbosa-Filho JM; Pires AL; Martins MA; Souza HS; Bandeira-Melo C; Bozza PT; Piuvezam MR
Int Immunopharmacol; 2012 Jun; 13(2):148-55. PubMed ID: 22480776
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of airway hyperreactivity and T helper cell type 2 responses by coumarins from Peucedanum praeruptorum Dunn in a murine model of allergic airway inflammation.
Xiong YY; Wu FH; Wang JS; Li J; Kong LY
J Ethnopharmacol; 2012 May; 141(1):314-21. PubMed ID: 22401763
[TBL] [Abstract][Full Text] [Related]
15. Methacholine-induced pulmonary gas trapping in a mouse model of allergic asthma: effect of inhaled budesonide and ciglitazone.
Stengel PW; Zeckner DJ; Guo WK; Wolos JA; Snyder DW
Eur J Pharmacol; 2008 Jan; 578(1):65-75. PubMed ID: 17900559
[TBL] [Abstract][Full Text] [Related]
16. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
[TBL] [Abstract][Full Text] [Related]
17. The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma.
Clayton RA; Dick CA; Mackenzie A; Nagasawa M; Galbraith D; Hastings SF; MacKenzie SJ
Respir Res; 2004 May; 5(1):4. PubMed ID: 15169552
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration.
Kuss H; Hoefgen N; Johanssen S; Kronbach T; Rundfeldt C
J Pharmacol Exp Ther; 2003 Oct; 307(1):373-85. PubMed ID: 12944497
[TBL] [Abstract][Full Text] [Related]
19. Hesperetin-7,3'-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio.
Yang YL; Hsu HT; Wang KH; Han CY; Chen CM; Chen CM; Ko WC
J Biomed Sci; 2011 Nov; 18(1):84. PubMed ID: 22074248
[TBL] [Abstract][Full Text] [Related]
20. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets.
Aoki M; Fukunaga M; Kitagawa M; Hayashi K; Morokata T; Ishikawa G; Kubo S; Yamada T
J Pharmacol Exp Ther; 2000 Dec; 295(3):1149-55. PubMed ID: 11082452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
